Paradigm Biopharmaceuticals Limited (ASX: PAR) Responds to ASX Price Query
Paradigm Biopharmaceuticals responds to ASX regarding recent trading activities and updates on its clinical trial submissions.
Category: Healthcare
Empire Resources Limited (ASX: ERL) Announces Yuinmery Aircore Drilling Results
Empire Resources (ASX: ERL) announces successful aircore drilling results at Yuinmery Project, confirming significant mineralisation extensions.
4DMedical Limited (ASX:4DX) Secures Contract with IPOC
4DMedical (ASX:4DX) announces a pivotal commercial contract with IPOC, enhancing its lung health diagnostic capabilities.
Pro Medicus Ltd (ASX:PME) Reports Strong FY2024 Results
Pro Medicus Ltd (ASX:PME) announces record FY2024 revenue and profit, with increased dividends and a strong growth outlook.
Capitol Health Limited (ASX: CAJ) Merger Update
Capitol Health provides an update on its merger with Integral Diagnostics, focusing on ACCC engagement and potential clinic divestments.
Amplia Therapeutics Limited (ASX:ATX) Announces Option Suspension
Amplia Therapeutics Limited (ASX:ATX) announces an immediate suspension of its options from quotation on the ASX.
Vection Technologies Ltd (ASX: VR1) Unveils AI-Driven Solutions
Vection Technologies Ltd (ASX: VR1) reports remarkable growth in AI and XR solutions, enhancing enterprise operations and customer engagement.
XRF Scientific Ltd (ASX:XRF) Acquires Labfit
XRF Scientific Ltd announces the acquisition of Labfit, expanding its product portfolio and market reach.
Lynch Group Holdings Limited (ASX: LGL) Reports FY24 Performance and Outlook
Lynch Group Holdings Limited reports FY24 financial results, sustainability initiatives, and forecasts revenue growth amid varied market conditions.
Apollo Minerals Limited (ASX:AON) Reports Visible Gold Intersected at Salanie
Apollo Minerals (ASX:AON) reports visible gold at Salanie and plans a capital raising to support exploration activities.